Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lifitegrast Phase 2 in Dry Eye
NCT00926185Phase 2Completed
- Sponsor
- Takeda
- Start
- Aug 2009
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lifitegrast in dry eye disease (DED) (4 arms), sponsored by Takeda. Primary endpoint: Inferior Corneal Fluorescein Staining Score in Pre-Controlled Adverse Environment at Day 84. Started Aug 2009; status: completed.
02
Drugs
lifitegrast
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT00926185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00926185.